EBS - Emergent BioSolutions to Release Fourth Quarter & Full Year 2023 Financial Results and Conduct Conference Call on March 6 2024 | Benzinga
GAITHERSBURG, Md., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) will host a conference call on Wednesday, March 6, 2024, at 5:00 pm eastern time to discuss the financial results for the fourth quarter and full year 2023. Emergent's newly appointed president and CEO, Joseph C. Papa, will provide remarks.
Conference Call Information
Participants can access the conference call live via webcast from the Investors page of Emergent's website. To participate via telephone, please register in advance at this